**Core Concept**
The patient's presentation with abdominal pain, distension, ascites, dyspnea, and elevated CA 125 levels suggests a diagnosis related to ovarian pathology, specifically epithelial ovarian cancer. The elevated CA 125 tumor marker is a common feature of this condition.
**Why the Correct Answer is Right**
The patient's symptoms and laboratory findings are consistent with advanced epithelial ovarian cancer. The malignant cells in the ovaries produce CA 125, leading to its elevation in the blood. The tumor cells can also invade and metastasize to other organs, causing ascites and dyspnea. The abdominal pain and distension are due to the tumor's mass effect and potential bowel obstruction.
**Why Each Wrong Option is Incorrect**
**Option A:** Ovarian torsion is a possible cause of acute abdominal pain in women, but it does not typically present with elevated CA 125 levels or ascites. It is a more localized condition that may not involve the entire abdomen.
**Option B:** Endometriosis is a condition where endometrial tissue grows outside the uterus, leading to pelvic pain and potentially causing intestinal obstruction. However, it does not typically present with elevated CA 125 levels or ascites, and it is not associated with ovarian cancer.
**Option C:** Pelvic inflammatory disease (PID) is a bacterial infection of the female reproductive organs, which can cause abdominal pain, fever, and pelvic tenderness. However, it does not typically present with elevated CA 125 levels or ascites, and it is not associated with ovarian cancer.
**Clinical Pearl / High-Yield Fact**
Elevated CA 125 levels can be seen in various conditions other than ovarian cancer, including benign ovarian cysts, endometriosis, and pelvic inflammatory disease. However, in the context of abdominal pain, distension, ascites, and dyspnea, ovarian cancer should be considered a high-yield diagnosis.
**Correct Answer: B. Endometriosis.**
Free Medical MCQs Β· NEET PG Β· USMLE Β· AIIMS
Access thousands of free MCQs, ebooks and daily exams.
By signing in you agree to our Privacy Policy.